Tag: online tool

‘Google Earth’ for Human Organs Made Available Online

A new open-access 3D portal that allows users to explore human organs in unprecedented detail, from the whole organ to individual cells, has been launched by an international team led by UCL scientists.

The Human Organ Atlas, described in a new paper in the journal Science Advances, brings together some of the most detailed images of 3D organs ever produced. It enables scientists, doctors, educators, students and the wider public to interactively “fly through” organs such as the brain, heart, lungs, kidney and liver, providing a new way of understanding human anatomy and human diseases.

The resource can be accessed directly through a standard web browser, without specialist software, at this link.

The Atlas is powered by an advanced X-ray imaging method called Hierarchical Phase-Contrast Tomography (HiP-CT), developed at the European Synchrotron (ESRF) in Grenoble, France. HiP-CT uses the ESRF’s Extremely Brilliant Source – a new generation of synchrotron source – which is up to 100 billion times brighter than conventional hospital CT scanners.

This allows researchers to scan entire intact ex vivo human organs (i.e., donated organs) non-destructively and then zoom in to near-cellular resolution (down to less than one micron, 50 times thinner than the size of a human hair).

The technique bridges a century-old gap in medicine between radiology and histology, and represents a major advance in biomedical imaging.

Professor Peter Lee (UCL Department of Mechanical Engineering), principal investigator of the Human Organ Atlas beamtime, said: “To create the Human Organ Atlas, we brought together scientists and medics from nine institutes worldwide. This grouping is continuing to expand, helping gain new insights into diseases from osteoarthritis to heart disease and changing how we learn about the human body.”

Dr Claire Walsh (UCL Department of Mechanical Engineering), Director of the Human Organ Atlas Hub, said: “The Human Organ Atlas shows what team science can achieve at its best – we went into this project wanting this data to be used by others and to help further the understanding of human physiology. The Human Organ Atlas is an incredible resource that will continue to grow. I am personally hugely excited to see how the AI community use the Human Organ Atlas in AI foundation models.”

From Covid-19 to cardiac and gynaecological disorders

Initially developed during the COVID-19 pandemic, the method has already led to high-impact publications and scientific advancements, revealing previously unseen microscopic vascular injury in the lungs of patients who died from Covid-19 or reshaping understanding of cardiac disorders. The technology has also been applied to other organs, providing new insights, for instance, into the way gynecological disorders develop.

Professor Judith Huirne, based at Amsterdam UMC, said: “The virtual 3D histological data derived from Human Organ Atlas hub provides us with valuable insights into the pathogenesis of gynecological disorders. This knowledge is crucial to bridging the current gaps in both understanding and gender disparities.”

This Human Organ Atlas portal is the result of more than five years of collaborative effort between many researchers, engineers, clinicians, and infrastructure specialists, united within the Human Organ Atlas Hub, a consortium involving nine institutes across Europe and the United States.

Since its inception, the team has been committed to open science. Dr Paul Tafforeau, ESRF scientist and pioneer of the imaging technique used to create the Human Organ Atlas, said: “From the beginning, we wanted these data to be accessible to everyone and build an open, shared scientific infrastructure at a global scale. This is a resource for researchers, doctors, educators – but also for anyone curious about how the human body is built.

A unique tool for AI, medicine and education

To the team’s knowledge, this is the highest-resolution open 3D dataset of intact human organs currently available. The Human Organ Atlas currently provides access to: (to be updated)

  • 62 organs, 319 full 3D datasets from 29 donors
  • 12 organ types, including brain, heart, lung, kidney, liver, colon, eye, spleen, placenta, uterus, prostate and testis
  • Multiscale scans, from whole-organ views down to near-cellular resolution (routinely down to 2 µm, as fine as 0.65 microns for some organs)

The portal has been designed to extend far beyond specialist research laboratories. Each dataset can reach hundreds of gigabytes or even over a terabyte in size. The largest one (a brain) is 14 Tb. To make the data usable worldwide, the portal provides:

  • Interactive browser-based visualisation (no special software required)
  • Downloadable datasets at multiple resolutions
  • Tutorials and software tools for analysis
  • Regular addition of new data

Beyond advancing anatomical and biomedical research, the atlas is expected to become a major resource for artificial intelligence. Large, high-quality 3D datasets are rare – limiting the development of advanced medical AI systems. The Human Organ Atlas provides a curated, hierarchical dataset ideally suited for training machine-learning models for segmentation, disease detection and super-resolution analysis.

At the same time, it offers powerful new opportunities for medical education and public engagement with science, allowing anyone to explore the human body out of curiosity.

Source: University College London

New Online Tool for Hard-to-identify Breast Cancer

A new diagnostic scoring system, developed by renowned breast cancer experts, is now available as an easy-to-use online tool through Susan G. Komen®, the world’s leading breast cancer organisation. This tool will help health care providers recognise and effectively diagnose a rare and aggressive breast cancer, inflammatory breast cancer.

The new Inflammatory Breast Cancer (IBC) Scoring System online tool is available at https://www.komen.org/ibc and may help to increase diagnostic accuracy, predict outcomes, guide treatment decisions and inclusion in clinical trials.  

Before the development of the proposed IBC Scoring System, IBC lacked a formal, objective medical definition and diagnosis was often delayed, misdiagnosed or missed altogether. The new online tool is intended to provide the proposed IBC diagnostic criteria in a convenient tool to help more quickly and effectively recognize IBC in the clinic. 

IBC often develops rapidly and can easily be confused with a breast infection because of symptoms such as redness and swelling, and the frequent lack of a breast lump. IBC can be hard to see on a mammogram as it may only show up as skin thickening. This results in approximately 30% of IBC patients being first diagnosed at stage IV (de novo metastatic breast cancer), meaning their breast cancer has already spread to other parts of the body. 

“IBC has historically been difficult to diagnose and no changes to diagnostic approach have been made since the 1960s,” said Dr Reshma Jagsi, Komen Scholar and Lawrence W. Davis Professor and Chair of the Department of Radiation Oncology at Emory University School of Medicine. “This first-of-its-kind tool may help health care providers recognise and diagnose IBC and may also enable researchers to study the biology of IBC, making discoveries to advance progress toward personalized care for all IBC patients in the future.”

The proposed IBC Scoring System was developed through a collaborative effort between Susan G. Komen, the Inflammatory Breast Cancer Research Foundation (IBCRF) and the Milburn Foundation, which brought together a team of leading breast cancer experts including clinicians, researchers, and IBC patients.  It is now being validated by a team of researchers at two of the largest IBC centres in the world led by Dr Filipa Lynce at Dana-Farber Cancer Institute, and Dr Wendy A. Woodward at MD Anderson Cancer Center. This work validating the scoring system is supported by a grant awarded by Susan G. Komen and is part of the groups’ collaborative efforts to advance IBC research and care through innovative approaches.

“I encourage my fellow health providers to use the IBC Scoring System when addressing patients having concerns about changes in their breast, such as swelling and redness. Using this tool may accelerate the diagnosis of IBC and start treatment at an earlier stage for those who have a confirmed diagnosis of invasive breast cancer,” said Dr Lynce.

“The creation of this tool reflects the deep commitment of Komen, the Inflammatory Breast Cancer Research Foundation and the Milburn Foundation to accelerate progress in detecting and treating inflammatory breast cancer. With the help of leading scientists and medical providers across the US, we will help thousands of patients receive an earlier and more accurate diagnosis of this aggressive disease and get the high-quality care they need to survive,” said Senior Vice President of Mission for Susan G. Komen, Victoria Wolodzko Smart. “I have no doubt this tool will improve outcomes for all IBC patients in the future.”

Source: EurekAlert!